Second medical use dosage regimen claim successfully traverses both insufficiency and “obvious-to-try” attacks (T 0799/16)
http://ipkitten.blogspot.com/2021/03/second-medical-use-dosage-regieme-claim.html The decision in T 0799/16 is a rare example of dose claim found both sufficient and inventive by the EPO Boards of Appeal. The claim was found to be sufficiently disclosed over the entire scope of the claim, despite the claimed treatment being shown as non effective in almost two thirds of... Continue reading